Th2 cytokines, IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice

Clinical and Experimental Immunology

Volumn 132, Issue 3, 2003, Pages 385-392

  Yokozeki, Hiroo ^a   Wu, M H ^a   Sumi, K ^a   Igawa, K ^a   Miyazaki, Y ^a   Katayama, I ^b   Takeda, K ^c   Akira, S ^c   Nishioka, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Contact hypersensitivity; IgE mast cells; Paraphenylenediamine (PPD); Th2 cytokines

Indexed keywords

1,3 PHENYLENEDIAMINE; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 4; INTERLEUKIN 5; PHENYLENEDIAMINE; STAT6 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTACT ALLERGY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; GENE DISRUPTION; MAST CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN MANIFESTATION; TH2 CELL;

ADOPTIVE TRANSFER; ANIMALS; CYTOKINES; DERMATITIS, CONTACT; FEMALE; IMMUNOGLOBULIN E; MAST CELLS; MICE; MICE, INBRED C57BL; PHENYLENEDIAMINES; STAT6 TRANSCRIPTION FACTOR; TH2 CELLS; TRANS-ACTIVATORS; TUBERCULIN;

EID: 0038810238     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02164.x     Document Type: Article

References (38)

1. Fisher AA. Contact Dermatitis, 3rd edn. Lea & Febiger, Philadelphia 1986:381-2.
2. Edward EK, Edward EK Jr. Contact urticaria and allergic contact dermatitis caused by paraphenylenediamine. Cutis 1984; 34:87-8.
3. Mayer RL. Group-sensitization to compounds of quinone structure and its biochemical basis role of these substances in cancer. Progr Allerg 1954; 4:79.
4. Blohm SG, Rajka G. The allergenicity of paraphenylenediamine I, Acta Der matovener (Stockholm). 1970; 50:49-51.
5. Magnusson B. The allegenicity of paraphenelenediamine versus that of paratoluenediamine. Contact Dermatitis Newsletter 1974; 15:432.
6. Yokozeki H, Watanabe K, Igawa K, Miyazaki Y, Katayama I, Nishioka K. γσT cells assist αβT cells in the adoptive transfer of contact hypersensitivity to para-phenylenediamine. Clin Exp Immunol 2001; 125:351-9.
7. Yokozeki H, Ghoreishi M, Takagawa S et al. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med 2000; 191:995-1004.
8. Gershon RK, Askenase PW, Gershon MD. Requirement for vasoactive amines for production of delayed-type hypersensitivity skin reaction. J Exp Med 1975; 142:732-47.
9. Galli SJ, Dvorak AM. What do mast cells have to do with delayed hypersensitivity? Laboratory Invest 1984; 50:365-8.
10. v and SI/SId mast cell-deficient mice. J Immunol 1983; 131:2687-94.
11. Miyachi Y, Imamaura S, Tokura Y, Takigawa M. Mechanisms of contact hypersensitivity in mice. VII. Diminished elicitation by reserpin and defective expression in mast cell-deficient nice. J Invest Dermatol 1986; 87:39-41.
12. Geba GP, Ptak W, Anderson GM, Paliwal V, Ratzlaff RE, Levin J, Askenase PW. Delayed-type hypersensitivity in mast cell-deficient mice. Dependence on platelets for expression of contact sensitivity. J Immunol 1996; 154:557-65.
13. Thomas WR, Schrader JW. Delayed hypersensitivity in mast cell-deficient mice. J Immunol 1983; 130:2565-7.
14. Galli SJ, Hammel I. Unequivacal delayed hypersensitivity inmast cell-deficient and beige mice. Science 1984; 226:710-3.
15. Ha T-Y, Reed ND, Crowle PK. Immune response potential of mast cell-deficient W/Wv mice. Int Arch Allergy Apppl Immunol 1986; 80:85-94.
16. Mekori YA, Chang JCC, Wershil BK, Galli S. Studies of the role of mast cells in contact sensitivity response. Cell Immunol 1986 1987; 109:39-52.
17. Ptak W, Geba GP, Askenase PW. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody, Mediation by serotonine and inhibition by histamine. J Immunol 1991; 146:3929-36.
18. Matsuda H, Ushio H, Paliwal V, Ptak W, Askenase PW. Adoptive cell transfer of contact sensitivity-initiation mediated by nonimmune cells sensitized with monoclonal IgE antibodies. J Immunol 1995; 154:5080-92.
19. Takeda KT, Tanaka W, Shi M et al. Essential role of Stat6 in IL-4 signaling. Nature 1996; 380:627-30.
20. Ferguson T, Dube P, Griffith TS. Regulation of contact hypersensitivity by interleukin 10. J Exp Med 1994; 179:1597-674.
21. Traidl C, Jugert F, Krieg T, Merk H, Hunzelmann N. Inhibition of allergic contact dermatitis to DNCB but not to Oxazolone in Interleukin-4-deficient mice. J Invest Dermatol 1999; 112:476-82.
22. Xu H, DiIulio NA, Fairchild RI. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon γ-producing (Tc1) effector CD8+ T cells and interleukin (IL)-4/IL-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996; 183:1001-12.
23. Steinbrink K, Sorg C, Macher E. Low zone tolerance to contact allergens in mice: a functional role for CD8+ T helper type 2 cells. J Exp Med 1996; 183:759-68.
24. Gocinsli BL, Tigelaar RE. Role of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990; 144:4121-8.
25. Dieli F, Asherson GL, Romano GC, Sireci G, Gervasi F, Salerno A. IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. J Immunol 1994; 152:2698-704.
26. Salerno A, Dieli F, Sireci G, Bellavia A, Asherson GL. IL-4 is a critical cytokine in contact sensitivity. Immunol 1995; 84:404-9.
27. Asherson G, Dieli LF, Sireci G, Salerno A. Role of IL-4 in delayed type hypersensitivity. Clin Exp Immunol 1996; 103:1-4.
28. Szczepanik M, Ptak W, Askenease PW. Role of IL-4 in down-regulation of contact sensitivity by gammadelta T cells from tolerized T cell recptor alpha-/- mice. 1999; 98:63-70.
29. Takeda K, Kamanaka M, Tanaka T, Kishimoto T, Akira S. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol 1996; 157:3220-2.
30. Berg DJ, Leach MW, Kulm R, Rajewsky K, Muller W, Davidson NJ, Rennick D. IL-10 but not IL-4 is a natural suppression of cutaneous inflammatory responses. J Exp Med 1995; 182:99-108.
31. Muller KM, Jaunin F, Masouye I, Saurat J-H, Hauser C. Th2 cells mediate IL-4-dependent local tissue inflammation. J Immunol 1993; 150:5576-84.
32. Saulier M, Huang S, Aguet M, Ryffel B. Role of interferon-gamma in contact hypersensitivity assessed in interferon-gamma receprtor-deficient mice. 1995; 102:301-12.
33. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ. Signal transduction and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 1998; 16:939-48.
34. Akimoto T, Numata F, Tamura M, Takata Y, Higashida N, Takashi T, Takeda K, Akira S. Abrogation of bronchial eosinophilic inflammation and airway hypersensitivity in signal transducers and activators of transcription (STAT6)-deficient mice. J Exp Med 1998; 187:1597-42.
35. Miyata S, Matsuyama T, Kodama T, Nishioka Y, Kuribayashi K, Takeda K, Akira S, Suguta M. STAT6 deficiency in a mouse model of allergen airway inflammation abolishes eosinophilia but induces infiltration of CD8+ T cells. Clin Exp Allergy 1999; 29:114-23.
36. Solley GO, Gleich GJ, Jordan RE. The late phase of the immediate wheal and flare skin reaction: Its dependence upon IgE antibodies. J Clin Invest 1976; 58:408-20.
37. Warner JA, Pienkowski MM, Plaut M, Norman PS, Lichtenstein LM. Identification of histamine-releasing factor(s) in the late phase of cutaneous IgE-mediated reactions. J Immunol 1986; 136:2583-7.
38. Malaviya R, Uckun FM. Role of STAT6 in IgE receptor/Fcepsilon RI-mediated late phase allergic responses of mast cells. J Immunol 2002; 168:421-6.